Diferencia entre revisiones de «Ketorolac»
| Línea 29: | Línea 29: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Bleeding, MI, CVA, GI bleed/perforation, Hyperkalemia | |||
===Common=== | ===Common=== | ||
*Dispepsia, nausea, HA | |||
==Pharmacology== | ==Pharmacology== | ||
Revisión del 01:10 23 may 2015
General
- Type: NSAID
- Dosage Forms: 15 mg/mL, 30 mg/mL injection
- Common Trade Names: Toradol
Adult Dosing
- Acute pain:
- IM: 30-60 mg x 1 or 30 mg q6h
- IV: 30 mg x 1, then 15-30 mg q6h
- Black box warning against tx for > 5 days
Pediatric Dosing
- N/A
Special Populations
- Pregnancy Rating: C
- Lactation: Enters breast milk, use caution
- Renal Dosing
- Mild-Moderate impairment: Decrease dose by 50%
- Severe impairment or HD: Contraindicated
- Hepatic Dosing: No dose change, but may increase LFTs
Contraindications
- Allergy to class/drug
- Active or prior PUD, recent GIB
- Severe renal disease or HD
- Bleeding diathesis
Adverse Reactions
Serious
- Bleeding, MI, CVA, GI bleed/perforation, Hyperkalemia
Common
- Dispepsia, nausea, HA
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: